Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

CLES in advanced Parkinson's disease: long-term effects

April 28, 2021

Cell death finding may improve stroke management

April 28, 2021

New 2.5-year treatment data on vamorolone in Duchenne muscular dystrophy

April 28, 2021

Phase II study finds evidence of improvement with SEP-363856 in psychosis in schizophrenia

April 28, 2021

New kappa-opioid receptor agonists identified at Nippon Chemiphar

April 28, 2021

Pharmacological target for anorexia

April 28, 2021

Vertex to advance VX-548 into phase II development in acute pain

April 28, 2021

Reviva reports strong phase II data in schizophrenia

April 27, 2021

Roflumilast demonstrates cognition-enhancing effects in patients with schizophrenia

April 27, 2021

FDA removes clinical hold on IND application for VY-HTT01

April 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...